FDA Lifts Import Alert on AquAdvantage Salmon
AquaBounty operates a facility in Albany
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowMassachusetts-based AquaBounty Technologies, Inc. (NASDAQ: AQB), a biotechnology company focused on enhancing productivity in the aquaculture market with a large precense in east central Indiana, has announced the U.S. Food and Drug Administration has lifted its Import Alert, allowing the company to start farming AquAdvantage Salmon in Indiana. The company acquired the former Bell Fish Co. facility in Albany in 2017.
The company currently produces traditional Atlantic salmon at the Albany site, but will begin to raise AquAdvantage brand salmon eggs from Canada not that the alert is lifted.
“We are delighted that FDA has lifted the import alert, which will allow AquaBounty to begin producing and marketing AquAdvantage Salmon in the United States. As FDA notes in this announcement, our salmon was approved by the agency over three years ago based upon a very comprehensive science-based review process, which established that our salmon was safe, nutritious, and environmentally sound and met all other regulatory requirements. We will immediately start the process to import AquAdvantage eggs from our hatchery in Canada to begin grow out at our Indiana facility,” said Sylvia Wulf, chief executive officer of AquaBounty, in a news release.